Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 20% ± 4% | |
| fibroblast | 6 studies | 21% ± 3% | |
| astrocyte | 5 studies | 21% ± 4% | |
| smooth muscle cell | 4 studies | 19% ± 4% | |
| epithelial cell | 4 studies | 26% ± 4% | |
| GABAergic neuron | 4 studies | 34% ± 8% | |
| oligodendrocyte | 4 studies | 16% ± 1% | |
| cardiac muscle cell | 3 studies | 18% ± 2% | |
| muscle cell | 3 studies | 21% ± 3% | |
| glutamatergic neuron | 3 studies | 43% ± 8% | |
| basal cell | 3 studies | 20% ± 3% | |
| oligodendrocyte precursor cell | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 1727.75 | 459 / 459 | 100% | 22.54 | 1118 / 1118 |
| esophagus | 100% | 2186.75 | 1445 / 1445 | 100% | 11.53 | 183 / 183 |
| kidney | 100% | 1371.94 | 89 / 89 | 100% | 14.47 | 900 / 901 |
| uterus | 100% | 1615.80 | 170 / 170 | 100% | 19.58 | 458 / 459 |
| liver | 100% | 2724.96 | 226 / 226 | 100% | 18.27 | 405 / 406 |
| prostate | 100% | 1973.18 | 244 / 245 | 100% | 23.35 | 502 / 502 |
| brain | 100% | 1632.33 | 2630 / 2642 | 100% | 22.98 | 705 / 705 |
| thymus | 100% | 1461.51 | 652 / 653 | 100% | 24.83 | 603 / 605 |
| pancreas | 99% | 966.79 | 326 / 328 | 100% | 16.75 | 178 / 178 |
| ovary | 100% | 1579.23 | 180 / 180 | 99% | 11.28 | 427 / 430 |
| lung | 99% | 1508.63 | 575 / 578 | 100% | 14.94 | 1152 / 1155 |
| adrenal gland | 100% | 1687.39 | 258 / 258 | 99% | 15.95 | 228 / 230 |
| bladder | 100% | 2305.86 | 21 / 21 | 99% | 14.56 | 497 / 504 |
| intestine | 100% | 1593.45 | 966 / 966 | 98% | 13.52 | 518 / 527 |
| stomach | 100% | 1255.19 | 359 / 359 | 97% | 11.61 | 277 / 286 |
| skin | 100% | 1236.11 | 1807 / 1809 | 93% | 9.57 | 440 / 472 |
| adipose | 100% | 2005.95 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2393.11 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 13.16 | 29 / 29 |
| muscle | 100% | 5585.31 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 880.49 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 18.05 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.65 | 1 / 1 |
| heart | 97% | 2369.73 | 836 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 85% | 6.42 | 68 / 80 |
| peripheral blood | 32% | 273.67 | 297 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006457 | Biological process | protein folding |
| GO_0050821 | Biological process | protein stabilization |
| GO_0005829 | Cellular component | cytosol |
| GO_0031089 | Cellular component | platelet dense granule lumen |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0051082 | Molecular function | unfolded protein binding |
| GO_0051087 | Molecular function | protein-folding chaperone binding |
| GO_0031072 | Molecular function | heat shock protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CDC37L1 |
| Protein name | Hsp90 co-chaperone Cdc37-like 1 Hsp90 co-chaperone Cdc37-like 1 (Hsp90-associating relative of Cdc37) |
| Synonyms | HARC CDC37B |
| Description | FUNCTION: Co-chaperone that binds to numerous proteins and promotes their interaction with Hsp70 and Hsp90. . FUNCTION: Co-chaperone that binds to numerous proteins and promotes their interaction with Hsp70 and Hsp90. . |
| Accessions | B1AL69 ENST00000381854.4 ENST00000381858.5 Q7L3B6 |